Loading…

Exponent, Inc.EXPOCompetitor analysis, valuation and peers

United States · USD·Industrials›Engineering & Construction

Scientific and engineering consulting firm investigating product failures and providing expert litigation support.

Momentum leader 96
Mkt cap
$4.24B
US dollars, full cap
Free float
99%
of shares outstanding
$/day
$40.6M
20-day average traded
Fwd P/E
34.6×
forward earnings
ROIC−WACC
+32.1 pp
WACC 8.4%
Hurdle
+4 pp
Req g minus delivered
Next earnings
78 days
4 Feb 2027
Close · USD$89.16
1D+1.7%
1W+3.4%
1M+22.9%
3M+28.5%
6M+53.1%
YTD+28.4%
1Y+29.4%
ATR %2.7%
Beta0.37
52w lowhigh1.5% off high

What Exponent does

Scientific and engineering consulting firm investigating product failures and providing expert litigation support.

Bills clients for its consultants' time, so revenue grows with the number of staff and how many hours they bill. Most consultants hold advanced degrees in science and engineering, and independence from the client is part of what it sells.

Products and services

  • Failure analysis/forensic engineering
  • Litigation/expert witness support
  • Product safety/regulatory consulting

Customers

  • Corporations facing litigation/product liability
  • Insurance companies
  • Government agencies

Where it sits in the supply chain

  • Industrials
  • Engineering/scientific consulting
  • Failure analysis and litigation support

What could go right

  • Product liability/litigation activity
  • EV/battery and AI safety consulting demand

What could go wrong

  • Litigation cycle dependency
  • High dependence on senior technical staff retention

Moat: narrow (brand, IP / patents). Reputation and specialized multidisciplinary scientific expertise are hard to replicate quickly.

Headquarters: Menlo Park, California, US · Founded: 1967 · Employees: 1,212

Named competitors

Exponent at a glance

Size Exponent (EXPO) is a United States Industrials company (Engineering & Construction) with a market value of $4.24B, the 1296th largest of 3,085 United States companies the cockpit tracks. Shares closed at $89.16 on 18 Nov 2026.

Performance Over six months the shares gained 53.1%, against -13.0% for the median peer and -2.2% for the United States market (cap-weighted) — highest of 21 in its peer set.

Growth Revenue grew 15.3% over the last twelve months (peer median +9.3%); the operating margin is 21.3% (peer median 8.0%).

Valuation It trades at 34.6× forward earnings against a peer median of 14.8× (3rd most expensive of 21).

Price implies For today's price to make sense, revenue must grow about 12% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is +4 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 32.1 points above its cost of capital (8.4% WACC).

Short interest Short interest is 5.1% of the free float (30 Oct 2026).

Next results Next results expected around 4 Feb 2027 (exchange calendar; dates can move).

Relative performance

10012515021 May 202621 Aug 202618 Nov 2026EXPO 156Peer median 87
Six months, rebased to 100: Exponent against the median of its 20 peers (local-currency closes).

Exponent financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$659M$582M$559M$537M$513M
Revenue growth—+4%+4%+5%—
Gross profit$168M$145M$142M$136M$165M
EBITDA$151M$130M$129M$120M$148M
Net income$115M$106M$109M$100M$102M
Free cash flow$141M$122M$138M$111M$81.8M
Capital expenditure$8.07M$9.39M$6.94M$16.4M$12.0M
Total debt$81.1M$82.8M$81.5M$28.3M$18.6M

Quarterly statements and history in the cockpit →

Exponent competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%-25%0%+25%+50%0%+20%MYRGRVNLAGX60058306590257ARCAD000429ECG5076ROAD60356860161161391735LGNBAMNB1721600667BDXEXPO6-month return →1-month return →
Up and to the right = strong over both horizons. Exponent is the large dot.

Fundamentals: revenue growth against valuation

0%+25%+50%+75%10×20×30×40×MYRGRVNLAGX60058306590257ARCAD000429ECG5076ROAD60356860161161391735LGN600667BDXEXPORevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Exponent is the large dot.

Capital: growth delivered against growth the price implies

0%+25%+50%+75%0%50%MYRGAGX06590257ARCAD5076ROAD6139LGNBAMNBEXPOGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Exponent is the large dot.

Exponent competitors and peer comparison

Head to head with its named competitors (EXPO vs CRAI vs ICFI vs FCN)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Exponent EXPO$4.24B+53%+15%21%34.6×11.8%
CRA International CRAI$1.35B+46%+13%10%23.3×6.6%
ICF International ICFI$1.40B+14%-5%8%10.4×-2.5%
FTI Consulting FCN$5.63B+34%+8%10%19.7×-2.5%
Huron Consulting HURN$2.68B+58%+12%12%16.7×-3.4%

How Exponent compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Exponent against its 20 peers (data as of 18 Nov 2026)
MeasureEXPOPeer medianRank in peer set
1-month return+22.9%-1.9%highest of 21
6-month return+53.1%-13.0%highest of 21
Distance from 52-week high-1.5%-39.6%highest of 21
Revenue growth (TTM)+15.3%+9.3%9th highest of 21
Operating margin21.3%8.0%4th highest of 21
Forward P/E34.6×14.8×3rd most expensive of 21
Growth the price implies (Req g, 7 yrs)11.8%5.8%7th most demanding of 16
Growth delivered (Del g)+7.8%+10.7%6th lowest of 16
Hurdle (Req g minus delivered)+4.1 pp-2.3 pp5th most demanding of 16
ROIC minus cost of capital+32.1 pp+0.0 pphighest of 18
EV / EBITDA27.9×11.6×most expensive of 14
Net debt / EBITDA-0.2×1.0×7th least indebted of 16

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Exponent EXPOUnited States$4.24B+53%+15%21%34.6×11.8%+7.8%
MYR MYRGUnited States$4.24B-39%+23%6%18.7×14.9%+10.2%
Rail Vikas Nigam RVNL.NSIndia$4.22B-30%+2%4%39.4×n/an/a
Argan AGXUnited States$4.26B-52%+29%15%22.4×2.9%+19.2%
Offshore Oil Engineering 600583.SSChina$4.21B+4%+7%8%12.1×n/an/a
CTF Services 0659.HKHong Kong$4.21B+4%+12%11%11.3×-1.0%-0.8%
China Everbright Environment 0257.HKHong Kong$4.20B-8%-5%29%7.5×1.0%-8.5%
Arcadis ARCAD.ASNetherlands$4.33B+30%-1%6%15.1×5.8%+8.1%
Guangdong Provincial Expressway Development 000429.SZChina$4.13B+7%+1%58%18.8×n/an/a
Everus Construction ECGUnited States$4.37B-42%+33%8%12.6×15.9%+11.5%
INFRONEER 5076.TJapan$4.43B-11%+53%6%6.6×4.1%+10.7%
Construction Partners ROADUnited States$4.43B-31%+42%9%29.2×13.2%+29.1%
Zhejiang Weiming Environment Protection 603568.SSChina$4.05B-23%-25%36%11.5×6.6%+15.0%
China Nuclear Engineering and Construction 601611.SSChina$3.94B-32%-14%4%25.1×n/an/a
L&K Engineering 6139.TWTaiwan$3.92B-15%+68%17%6.5×-20.4%+41.0%
Central New Energy 1735.HKHong Kong$4.59B-16%+76%1%65.6×n/an/a
Legence LGNUnited States$3.90B-56%+84%6%12.7×25.3%+84.2%
Koninklijke BAM Groep BAMNB.ASNetherlands$3.88B+33%+7%3%11.9×-4.5%+0.8%
Comsys 1721.TJapan$3.81B-6%+6%9%14.5×0.9%+2.3%
Wuxi Taiji Industry 600667.SSChina$3.79B-2%-14%3%20.8×12.2%+11.5%
Budimex BDX.WAPoland$4.77B+9%+12%9%26.6×16.2%+4.1%

Questions

Who are Exponent's main competitors?
Named competitors: Charles River Associates (CRAI), ICF International (ICFI), FTI Consulting (FCN), Huron Consulting (HURN). The cockpit's measured peer set (industry) also includes MYR (MYRG), Rail Vikas Nigam (RVNL.NS), Argan (AGX), Offshore Oil Engineering (600583.SS), CTF Services (0659.HK), China Everbright Environment (0257.HK).
Is Exponent expensive compared with its peers?
On forward p/e it trades at 34.6× against a peer median of 14.8×, 3rd most expensive of 21 in its peer set. For today's price to make sense, revenue must grow about 12% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is +4 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Exponent stock performed?
Over six months to 18 Nov 2026 the shares returned +53.1% against -13.0% for the median peer; over one year +29.4%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.